◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › D › DRW3

Drägerwerk AG & Co. KGaA (DRW3) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-16

Drägerwerk AG & Co. KGaA (DRW3) operates in the Medical Devices industry and is headquartered in Lübeck, Germany with about 16,009 employees. Its market capitalization is roughly €2 billion. In the fiscal year ended 2025-12-31, DRW3 reported €3.5B in revenue and €140M in net income.

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.

Interactive charts & full statements →

DRW3 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	€3.5B	€3.4B	€3.4B	€3.0B
Gross Profit	€1.6B	€1.5B	€1.5B	€1.2B
Operating Income (EBIT)	€232M	€180M	€184M	(€80M)
Net Income	€140M	€124M	€110M	(€65M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DRW3 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	€847M	€756M	€1.1B	€780M	€730M
Gross Profit	€395M	€350M	€518M	€342M	€335M
Operating Income (EBIT)	€46M	€19M	€154M	€19M	€2M
Net Income	€30M	€11M	€95M	€11M	(€2M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DRW3 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(€38M)	(€33M)	(€4M)	(€4M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DRW3 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	(€42M)	—	€0M	(€38M)	—	€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

DRW3 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€3.2B	€3.1B	€3.1B	€3.1B	—
Total Liabilities	€1.5B	€1.6B	€1.7B	€1.8B	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DRW3 viewer.

Other Companies in Medical Devices

UFPT · UFP Technologies, Inc. — $2 billion
6669 · Acotec Scientific Holdings Limited — $2 billion
ESTA · Establishment Labs Holdings Inc. — $2 billion
BFLY · Butterfly Network, Inc. — $2 billion
NVCR · NovoCure Limited — $2 billion
ALMR · Alamar Biosciences, Inc. — $2 billion
6609 · Shanghai HeartCare Medical Technology Corporation Limited — $2 billion
INSP · Inspire Medical Systems, Inc. — $2 billion

← DRVN All “D” companies DRW8 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.